EMERYVILLE, Calif., July 20, 2023 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq:DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report second quarter 2023 financial results on Thursday, August 3, 2023, after the U.S. financial markets close.
Read more at prnewswire.comDynavax to Report Second Quarter 2023 Financial Results and Host Conference Call on August 3, 2023
PR Newswire -
Thu Jul 20, 2023
Columnist
Contributor Content
Press Release
Sponsored Content
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Green%20hydrogen%20by%20Scharfsinn%20via%20Shutterstock.jpg)
/AI%20(artificial%20intelligence)/Hands%20of%20robot%20and%20human%20touching%20on%20big%20data%20network%20connection%20by%20PopTika%20via%20Shutterstock.jpg)
